, also known by the brand names of Niravam
, and Xanax
, is a benzodiazepine-class, short-acting medication used to manage moderate to severe panic attacks and anxiety
disorders. It is also used as an auxiliary treatment for anxiety caused by moderate depression
. It's available in both generic form and extended release form (Xanax XR). In America, this medication is a schedule IV controlled substance under the Controlled Substances Act.
Those who suffer from severe anxiety disorders, panic attacks, and even those with anxiety produced by moderate depression may use this medication. Patients should be duly warned that this medication is habit-forming, so long-term use and/or abuse may cause you to develop a physical dependence on Trankimazin, which includes withdrawal reactions during rapid or abrupt halting of treatment. This medication also has muscle-relaxant/sedative/anticonvulsant/hypnotic/anxiolytic properties.
Trankimazin should be taken orally as instructed by your physician. The dosage is based on your response to treatment and medical condition. You should use the dropper included with the product to cautiously measure the dose and mix it in soft food or liquid (water, applesauce, pudding) just before taking it.
As noted earlier, this medication is highly addictive, especially when used for a long period or in high doses. If you stop using this medication after you've become dependent on it, withdrawal reactions like seizures may occur. Report any such symptoms to your doctor as soon as you possibly can.
Common side effects of Trankimazin include dizziness
and drowsiness. If any of these symptoms continue or worsen, contact your pharmacist or healthcare specialist immediately. On that note, avoid working with heavy machinery or driving while taking this medication. Also inform your doctor promptly once the following rare but serious side effects occur: sleep disturbances, urination
difficulties, walking difficulties, decreased or increased interest in sex, clumsiness, slurred speech, and mood swings.
Consult with your doctor after any of these extremely rare but exceptionally serious side effects occur: persistent sore throat, fever
, signs of infection, dark urine, yellowing of your eyes or skin (jaundice), fatigue, persistent nausea
, and stomach
or abdominal pain.
You must also be wary of symptoms indicating an acute allergic reaction to the medication like breathing difficulties, severe dizziness, swelling
, and rash even though such occurrences are mostly unlikely. Contact your doctor or pharmacist and seek immediate medical care if any of the above mentioned symptoms arise.
Before taking this medication, inform your pharmacist or doctor if you're allergic to it or any other benzodiazepines like lorazepam
. You should then inform him if you have any other allergies
as well. From there, report your medical history to him, especially of severe lung
or breathing problems like COPD
and sleep apnea, kidney
disease, and drug or alcohol abuse. You must also limit your alcohol intake while undergoing Trankimazin therapy.
When stopping long-term and regular treatment with Trankimazin, you must first gradually reduce your dosage as directed by your doctor in order to avoid any severe withdrawal reactions. Constant consultation between your doctor and pharmacist is a must during this crucial time. The chances of a patient developing medication-seeking behavior after stopping therapy are rare but serious. You should seek prompt medical attention in case that side effect occurs.
This medication has been proven to pass into breast
milk, so you must not under any circumstances breastfeed while taking this medication. Furthermore, this medication should not be used during pregnancy as well because of the potential harm it could cause to your unborn child. Consult your healthcare specialist for further information.
Trankimazin has the following structural formula:
• Molecular formula of trankimazin is C17H13ClN4
• Chemical IUPAC Name is 8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
• Molecular weight is 308.765 g/mol
• Trankimazin available : 0,25mg tablets, 0,5mg tablets, 1mg tablets and 2mg tablets